These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24779767)

  • 1. Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.
    Tsao CT; Kievit FM; Wang K; Erickson AE; Ellenbogen RG; Zhang M
    Mol Pharm; 2014 Jul; 11(7):2134-42. PubMed ID: 24779767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-network poly(Nɛ-acryloyl L-lysine)/hyaluronic acid hydrogel as a mimic of the breast tumor microenvironment.
    Xu W; Qian J; Zhang Y; Suo A; Cui N; Wang J; Yao Y; Wang H
    Acta Biomater; 2016 Mar; 33():131-41. PubMed ID: 26805429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy.
    Tsao CT; Kievit FM; Ravanpay A; Erickson AE; Jensen MC; Ellenbogen RG; Zhang M
    Biomacromolecules; 2014 Jul; 15(7):2656-62. PubMed ID: 24890220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled breast cancer microarrays for the deconvolution of cellular multilayering and density effects upon drug responses.
    Håkanson M; Kobel S; Lutolf MP; Textor M; Cukierman E; Charnley M
    PLoS One; 2012; 7(6):e40141. PubMed ID: 22792141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment.
    Kievit FM; Florczyk SJ; Leung MC; Veiseh O; Park JO; Disis ML; Zhang M
    Biomaterials; 2010 Aug; 31(22):5903-10. PubMed ID: 20417555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus.
    Del Bufalo F; Manzo T; Hoyos V; Yagyu S; Caruana I; Jacot J; Benavides O; Rosen D; Brenner MK
    Biomaterials; 2016 Apr; 84():76-85. PubMed ID: 26826297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-physiological microenvironment simulation on chip to evaluate drug resistance of different loci in tumour mass.
    Wang S; Mao S; Li M; Li HF; Lin JM
    Talanta; 2019 Jan; 191():67-73. PubMed ID: 30262100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D hydrogel-based microwell arrays as a tumor microenvironment model to study breast cancer growth.
    Casey J; Yue X; Nguyen TD; Acun A; Zellmer VR; Zhang S; Zorlutuna P
    Biomed Mater; 2017 Mar; 12(2):025009. PubMed ID: 28143999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of MCF-7 breast cancer cells and efficacy of anti-angiogenic agents in a hydroxyethyl chitosan/glycidyl methacrylate hydrogel.
    Wang H; Qian J; Zhang Y; Xu W; Xiao J; Suo A
    Cancer Cell Int; 2017; 17():55. PubMed ID: 28515673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling.
    Pinto MP; Dye WW; Jacobsen BM; Horwitz KB
    BMC Cancer; 2014 Oct; 14():735. PubMed ID: 25274034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro angiogenesis induced by tumor-endothelial cell co-culture in bilayered, collagen I hydrogel bioengineered tumors.
    Szot CS; Buchanan CF; Freeman JW; Rylander MN
    Tissue Eng Part C Methods; 2013 Nov; 19(11):864-74. PubMed ID: 23516987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
    Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
    Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.
    Song G; Darr DB; Santos CM; Ross M; Valdivia A; Jordan JL; Midkiff BR; Cohen S; Nikolaishvili-Feinberg N; Miller CR; Tarrant TK; Rogers AB; Dudley AC; Perou CM; Zamboni WC
    Clin Cancer Res; 2014 Dec; 20(23):6083-95. PubMed ID: 25231403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogel Environment Supports Cell Culture Expansion of a Grade IV Astrocytoma.
    Jogalekar MP; Cooper LG; Serrano EE
    Neurochem Res; 2017 Sep; 42(9):2610-2624. PubMed ID: 28589519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
    Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
    Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-l-Lysine inhibits VEGF and c-Myc mediated tumor-angiogenesis and induces apoptosis in 2D and 3D tumor microenvironment of both MDA-MB-231 and B16F10 induced mice model.
    Debnath S; Mukherjee A; Saha D; Dash J; Chatterjee TK
    Int J Biol Macromol; 2021 Jul; 183():528-548. PubMed ID: 33892042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
    Helmi O; Elshishiny F; Mamdouh W
    Int J Biol Macromol; 2021 Aug; 184():325-338. PubMed ID: 34119547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
    Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
    Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RoY peptide-modified chitosan-based hydrogel to improve angiogenesis and cardiac repair under hypoxia.
    Shu Y; Hao T; Yao F; Qian Y; Wang Y; Yang B; Li J; Wang C
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6505-17. PubMed ID: 25756853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.